Düsseldorf, Germany, November 2024 – Medlander proudly participated in MEDICA 2024, the world’s largest and most influential medical trade fair, held from November 11 to 14. At the event, Medlander showcased its flagship products—the B4Plus, M4Plus, the MTS F series chair, and High Frequency Evaluation and Therapy Device—solidifying its reputation as a leader in pelvic floor physiotherapy and women’s wellness.

MEDICA 2024: A Global Medical Hub

This year’s MEDICA brought together over 5,500 exhibitors from nearly 70 countries, featuring the latest advancements in Lab & Diagnostics, Disposables, Physio tech, Digital health, and Med Tech & Devices. More than 120,000 attendees, including healthcare professionals, decision-makers, and industry leaders, gathered to explore cutting-edge innovations and foster global collaboration.

For Medlander, MEDICA 2024 was the perfect platform to showcase its expertise and innovations in pelvic floor health, contributing to the global conversation on improving patient outcomes with modern technologies.

Revolutionizing Pelvic Floor Care with Magnoelectrical Combination Therapy

Medlander’s magnoelectrical combination therapy was a standout feature at the exhibition. By integrating magnetic stimulation, electrical stimulation, and biofeedback, this advanced technology offers a comprehensive solution for pelvic floor dysfunction (PFD). Compared to traditional electrical stimulation, it provides faster results and is effective for a broader range of patients.

Widely adopted by hospitals in China and abroad, Medlander’s devices are celebrated for their non-invasive design, user-friendly interfaces, and proven clinical outcomes. The company’s flagship products, biofeedback and electrical stimulation, magnetic stimulation, as well as its AI diagnostic system—PI-ONE system, are recognized for their precision, adaptability across clinical scenarios, and consistent therapeutic effectiveness, making them a trusted choice for healthcare providers worldwide.

Highlights from the Medlander Stand at MEDICA 2024

Medlander showcased its flagship products, the B4Plus, M4Plus, the MTS F chair, and High Frequency Evaluation and Therapy Device in the sphere of “Physio tech”. In this four-day event, they attracted a steady flow of visitors who were particularly interested in the innovations for the non-invasive and point-of-care PFD treatment.

The team provided live demonstrations of the MTS F Chair, showcasing its non-invasive treatment capabilities for stress urinary incontinence and chronic prostatitis. Visitors were impressed by its user-friendly interface and convenience in delivering effective care.

A highlight was the demonstration of Medlander’s Biofeedback and Electrical Stimulation technology through a mock scenario by M4Plus, featured by EMG graphs for pelvic floor assessment and treatment sessions, along with the use of body surface electrode patches in comprehensive and postpartum recovery. This versatile device is designed for use across multiple specialties, including gynecology, obstetrics, urology, and physiotherapy.

Medlander has actively worked to empower local practitioners and institutions in the field of pelvic floor health by providing comprehensive training and operational guidance. In Europe, the company has partnered with local distributors to supply training devices for hands-on practice in hospitals and clinics. Additionally, Medlander offers tailored operational advice to end-users, helping them design personalized treatment packages. This approach enables healthcare providers to deliver more customized, precise, and all-in-one therapy solutions for each patient, ensuring better outcomes and enhanced patient care.

Among all the products displayed at MEDICA 2024, the Biofeedback and Electrical Stimulation device M4Plus received particular praise for its portability and effectiveness from our existing European clients. Its adaptability to various clinical settings makes it a standout choice for healthcare providers seeking advanced, flexible solutions for PFD treatment.

Looking Forward: Medlander’s Vision for the Future

As MEDICA 2024 concluded, Medlander celebrated its successful participation and the significant opportunities the event brought. The exhibition reaffirmed Medlander’s commitment to delivering innovative, patient-centered solutions for pelvic floor health.

With its established collaborations in China and growing partnerships in Europe and beyond, Medlander is poised to expand its global impact. The insights gained at MEDICA 2024 will guide the company as it continues to innovate and drive advancements in pelvic floor rehabilitation, setting new standards for patient care and empowering healthcare providers worldwide.

MEDICA 2024 was not just an exhibition for Medlander—it was a platform to inspire, engage, and innovate. We thank everyone who visited our stand and look forward to shaping the future of healthcare together.